Hip implant showdown: does a new design raise metal levels?
NCT ID NCT03371212
First seen Jan 10, 2026 · Last updated May 14, 2026 · Updated 20 times
Summary
This study looks at whether a newer type of hip replacement implant (modular dual mobility) leads to higher levels of metals like cobalt, chromium, and titanium in the blood compared to a standard implant. About 52 adults getting a first-time hip replacement will be randomly assigned to one of the two implant types. The main goal is to measure metal levels in the blood after surgery, not to treat or cure a disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SERUM METAL LEVELS, SPECIFICALLY COBALT, CHROMIUM, AND TITANIUM are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Rush University Medical Center
Chicago, Illinois, 60612, United States
Conditions
Explore the condition pages connected to this study.